+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Fully Automatic Molecular Diagnostic System Market - Global Forecast 2026-2032- Product Image
Fully Automatic Molecular Diagnostic System Market - Global Forecast 2026-2032- Product Image
Sale

Fully Automatic Molecular Diagnostic System Market - Global Forecast 2026-2032

  • Report

  • 188 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6150567
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Fully Automatic Molecular Diagnostic System Market is projected to reach USD 9.35 Billion in 2026. It is expected to continue growing at a CAGR of 12.57%, reaching USD 18.98 Billion by 2032.

Fully Automatic Molecular Diagnostic Systems: Executive Overview

Fully automatic molecular diagnostic systems integrate specimen handling, nucleic-acid extraction, amplification, detection, and result reporting within streamlined workflows. Their relevance is growing as laboratories seek faster turnaround, reduced manual intervention, consistent quality, and broader access to molecular testing. Adoption decisions increasingly depend on clinical utility, workflow compatibility, regulatory compliance, service support, and the ability to operate reliably across centralized and decentralized settings.

Automation Is Reshaping Molecular Diagnostic Workflows

The landscape is shifting from labor-intensive, multi-instrument processes toward integrated platforms that reduce hands-on steps and support standardized testing. Laboratories are prioritizing interoperability with information systems, traceability, contamination control, flexible test menus, and simplified maintenance. At the same time, decentralized testing is increasing demand for compact systems that preserve analytical performance while accommodating variable staffing, infrastructure, and specimen volumes. Procurement is therefore moving beyond instrument performance alone toward total workflow value, implementation readiness, and continuity of supply.

Artificial Intelligence Strengthens Interpretation, Operations, and Quality Control

Artificial intelligence can enhance fully automatic molecular diagnostics by supporting result interpretation, anomaly detection, quality-control review, predictive maintenance, and workload optimization. Algorithms may help identify signal patterns, flag potentially invalid runs, prioritize repeat testing, and connect molecular results with clinical or epidemiological data. However, effective deployment requires representative validation datasets, transparent performance monitoring, cybersecurity controls, human oversight, and clear accountability for clinically consequential decisions. AI is most valuable when integrated into governed workflows rather than treated as a substitute for laboratory expertise.

Regional Insights: Infrastructure and Access Shape Adoption

North America emphasizes automation, interoperability, reimbursement alignment, and regulatory evidence, with demand shaped by large laboratory networks and decentralized care. Latin America is influenced by uneven laboratory capacity, import dependence, public-health priorities, and the need for robust systems that can function across diverse settings. Europe places strong weight on quality management, data protection, cross-border diagnostic consistency, and compliance with evolving regulatory requirements. The Middle East is advancing through investments in healthcare infrastructure, centralized reference services, and specialized clinical programs, while procurement may depend on localization and training. Africa presents substantial need for dependable infectious-disease and public-health testing, with adoption tied to affordability, instrument resilience, workforce development, and supply continuity. Asia-Pacific combines advanced laboratory markets with rapidly expanding healthcare systems, creating demand for scalable automation, local service capability, and applications spanning infectious disease, oncology, and inherited disorders.

Group Insights: Policy Alignment and Network Scale Matter

ASEAN markets are linked by varied regulatory environments, uneven laboratory infrastructure, and priorities around infectious-disease surveillance and access, making modular systems and regional training especially relevant. BRICS members show differing levels of domestic manufacturing, public-sector capacity, and clinical adoption, with opportunities shaped by localization, procurement policy, and diagnostic self-reliance. The European Union prioritizes harmonized quality, data governance, and laboratory interoperability across member states. G7 settings generally have mature laboratory networks and stronger evidence requirements, encouraging automation that improves productivity without compromising oversight. GCC countries are investing in technologically advanced healthcare infrastructure and centralized services, while emphasizing workforce capability and operational resilience. NATO members may benefit from interoperable preparedness and coordinated approaches to biological-threat surveillance, although civilian health systems and regulatory conditions remain diverse.

Country Insights: Diverse Health Systems Require Adaptable Platforms

Australia’s dispersed geography increases the value of reliable remote-service models and systems suitable for regional laboratories. Brazil’s large and varied healthcare structure favors scalable platforms, local support, and public-health integration. Canada’s geography and provincial organization make interoperability, decentralization, and dependable logistics important. China is advancing laboratory automation alongside domestic technology development and broad clinical demand. France and Germany emphasize quality systems, regulatory compliance, and integration with established laboratory networks. India’s diverse infrastructure creates demand for cost-conscious automation, high-throughput capability, and simplified operation. Italy and Spain are shaped by public healthcare procurement, regional organization, and pressure to standardize workflows. Japan prioritizes reliability, precision, aging-population needs, and integration with sophisticated clinical environments. Mexico requires solutions that address unequal access, workforce variation, and public-sector testing priorities. Russia’s context includes geographic scale, domestic capability, and continuity of supply considerations. South Korea combines advanced digital health infrastructure with strong interest in efficient, connected diagnostics. The United Kingdom places emphasis on evidence, laboratory networks, health-system interoperability, and operational efficiency. The United States is characterized by complex regulation, diverse provider structures, strong demand for workflow automation, and attention to reimbursement and clinical validation.

Recommendations for Leaders: Build for Workflow, Resilience, and Trust

Industry leaders should define target use cases before selecting automation, distinguishing centralized high-throughput needs from near-patient or regional requirements. Platforms should be evaluated using end-to-end workflow measures, including hands-on time, invalid-run rates, turnaround consistency, maintenance burden, connectivity, and staff training requirements. Product roadmaps should support adaptable test menus, open and secure data exchange, and transparent AI governance. Organizations should also establish resilient supply chains, regional service capacity, validation protocols, cybersecurity safeguards, and post-deployment performance monitoring. Partnerships with laboratories, clinicians, public-health agencies, and regulators can improve evidence quality and accelerate responsible implementation.

Research Methodology: Evidence-Based Assessment of Market Dynamics

This executive summary applies a structured review of the fully automatic molecular diagnostic system landscape, focusing on documented technology capabilities, laboratory workflow requirements, regulatory considerations, healthcare infrastructure, and regional adoption conditions. Analysis distinguishes verified operational and policy trends from unsupported commercial claims. Regional, group, and country perspectives are synthesized from publicly available health-system characteristics, diagnostic priorities, laboratory practices, and regulatory environments. The assessment excludes market estimates, market sizing, market shares, forecasts, and company-specific comparisons, and interprets artificial intelligence in relation to validated clinical and operational use cases.

Conclusion: Automation Must Deliver Reliable, Connected Clinical Value

Fully automatic molecular diagnostic systems are becoming central to efforts to make molecular testing faster, more consistent, and less dependent on manual laboratory labor. Their long-term value will depend on more than automation alone: systems must demonstrate clinical usefulness, robust quality management, secure connectivity, serviceability, and adaptability across different health systems. Leaders that combine disciplined evidence generation with resilient operations and responsible AI integration will be better positioned to expand access while maintaining trust in molecular diagnostic results.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Fully Automatic Molecular Diagnostic System Market, by Product Type
7.1. Introduction
7.2. Consumables
7.2.1. Assay Cartridges
7.2.2. Kits
7.2.3. Reagents
7.3. Instruments
7.3.1. Mass Spectrometer
7.3.2. Microarray Analyzer
8. Fully Automatic Molecular Diagnostic System Market, by Technology
8.1. Introduction
8.2. Isothermal Amplification
8.2.1. HDA
8.2.2. Lamp
8.3. Mass Spectrometry
8.4. Microarray Analysis
8.5. Next Generation Sequencing
8.5.1. Ion Semiconductor
8.5.2. Nanopore
8.5.3. Sequencing Synthesis
8.6. Polymerase Chain Reaction
9. Fully Automatic Molecular Diagnostic System Market, by Application
9.1. Introduction
9.2. Cardiac Markers
9.3. Genetic Testing
9.3.1. Carrier
9.3.2. Neonatal
9.3.3. Prenatal
9.4. Infectious Disease
9.4.1. Bacterial
9.4.2. Fungal
9.4.3. Parasitic
9.4.4. Viral
9.5. Oncology
9.5.1. Hematological
9.5.2. Solid Tumor
10. Fully Automatic Molecular Diagnostic System Market, by End User
10.1. Introduction
10.2. Academic And Research Institutes
10.2.1. Biotech Companies
10.2.2. Universities
10.3. Diagnostic Laboratories
10.3.1. Independent Laboratories
10.3.2. Reference Laboratories
10.4. Hospitals
11. Fully Automatic Molecular Diagnostic System Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Fully Automatic Molecular Diagnostic System Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Fully Automatic Molecular Diagnostic System Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abbott Laboratories
15.2. Becton, Dickinson and Company
15.3. Bio-Rad Laboratories, Inc.
15.4. Biocartis Group NV
15.5. bioMérieux S.A.
15.6. Danaher Corporation
15.7. F. Hoffmann-La Roche Ltd
15.8. Hologic, Inc.
15.9. QIAGEN N.V.
15.10. Siemens Healthineers AG
15.11. Sysmex Corporation
15.12. Thermo Fisher Scientific Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Fully Automatic Molecular Diagnostic System Market, Years Considered for the Study
FIGURE 2. Global Fully Automatic Molecular Diagnostic System Market, Research Design
FIGURE 3. Global Fully Automatic Molecular Diagnostic System Market, Research Framework
FIGURE 4. Global Fully Automatic Molecular Diagnostic System Market, Data Triangulation
FIGURE 5. Global Fully Automatic Molecular Diagnostic System Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Fully Automatic Molecular Diagnostic System Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Fully Automatic Molecular Diagnostic System Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Fully Automatic Molecular Diagnostic System Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Fully Automatic Molecular Diagnostic System Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Fully Automatic Molecular Diagnostic System Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Fully Automatic Molecular Diagnostic System Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Fully Automatic Molecular Diagnostic System Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Fully Automatic Molecular Diagnostic System Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Fully Automatic Molecular Diagnostic System Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Fully Automatic Molecular Diagnostic System Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Fully Automatic Molecular Diagnostic System Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Fully Automatic Molecular Diagnostic System Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Fully Automatic Molecular Diagnostic System Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Fully Automatic Molecular Diagnostic System Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Fully Automatic Molecular Diagnostic System Market Segmentation & Coverage
TABLE 2. Global Fully Automatic Molecular Diagnostic System Market Size, 2017-2032 (USD Million)
TABLE 3. Global Fully Automatic Molecular Diagnostic System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Consumables Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Consumables Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Consumables Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Assay Cartridges Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Assay Cartridges Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Assay Cartridges Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Mass Spectrometer Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Mass Spectrometer Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Mass Spectrometer Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Microarray Analyzer Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Microarray Analyzer Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Microarray Analyzer Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Fully Automatic Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 26. Global Isothermal Amplification Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Isothermal Amplification Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Isothermal Amplification Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global HDA Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global HDA Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global HDA Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Lamp Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Lamp Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Lamp Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Mass Spectrometry Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Mass Spectrometry Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Mass Spectrometry Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Microarray Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Microarray Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Microarray Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Next Generation Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Next Generation Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Next Generation Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Ion Semiconductor Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Ion Semiconductor Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Ion Semiconductor Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Nanopore Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Nanopore Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Nanopore Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Sequencing Synthesis Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Sequencing Synthesis Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Sequencing Synthesis Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Polymerase Chain Reaction Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Polymerase Chain Reaction Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Polymerase Chain Reaction Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Fully Automatic Molecular Diagnostic System Market Size, by Application, 2017-2032 (USD Million)
TABLE 57. Global Cardiac Markers Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Cardiac Markers Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Cardiac Markers Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Genetic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Genetic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Genetic Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Carrier Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Carrier Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Carrier Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Neonatal Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Neonatal Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Neonatal Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Prenatal Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Prenatal Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Prenatal Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Infectious Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Infectious Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Infectious Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Bacterial Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Bacterial Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Bacterial Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Fungal Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Fungal Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Fungal Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Parasitic Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Parasitic Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Parasitic Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Viral Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Viral Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Viral Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Hematological Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Hematological Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Hematological Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Solid Tumor Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Solid Tumor Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Solid Tumor Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Fully Automatic Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
TABLE 97. Global Academic And Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Academic And Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Academic And Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Biotech Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Biotech Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Biotech Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Universities Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Universities Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Universities Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Independent Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Independent Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Independent Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Reference Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Reference Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Reference Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Fully Automatic Molecular Diagnostic System Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Asia-Pacific Fully Automatic Molecular Diagnostic System Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Asia-Pacific Fully Automatic Molecular Diagnostic System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 121. Asia-Pacific Fully Automatic Molecular Diagnostic System Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 122. Asia-Pacific Fully Automatic Molecular Diagnostic System Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 123. Asia-Pacific Fully Automatic Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 124. Asia-Pacific Fully Automatic Molecular Diagnostic System Market Size, by Isothermal Amplification, 2017-2032 (USD Million)
TABLE 125. Asia-Pacific Fully Automatic Molecular Diagnostic System Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 126. Asia-Pacific Fully Automatic Molecular Diagnostic System Market Size, by Application, 2017-2032 (USD Million)
TABLE 127. Asia-Pacific Fully Automatic Molecular Diagnostic System Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 128. Asia-Pacific Fully Automatic Molecular Diagnostic System Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 129. Asia-Pacific Fully Automatic Molecular Diagnostic System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 130. Asia-Pacific Fully Automatic Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
TABLE 131. Asia-Pacific Fully Automatic Molecular Diagnostic System Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
TABLE 132. Asia-Pacific Fully Automatic Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 133. North America Fully Automatic Molecular Diagnostic System Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. North America Fully Automatic Molecular Diagnostic System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 135. North America Fully Automatic Molecular Diagnostic System Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 136. North America Fully Automatic Molecular Diagnostic System Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 137. North America Fully Automatic Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 138. North America Fully Automatic Molecular Diagnostic System Market Size, by Isothermal Amplification, 2017-2032 (USD Million)
TABLE 139. North America Fully Automatic Molecular Diagnostic System Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 140. North America Fully Automatic Molecular Diagnostic System Market Size, by Application, 2017-2032 (USD Million)
TABLE 141. North America Fully Automatic Molecular Diagnostic System Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 142. North America Fully Automatic Molecular Diagnostic System Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 143. North America Fully Automatic Molecular Diagnostic System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 144. North America Fully Automatic Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. North America Fully Automatic Molecular Diagnostic System Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
TABLE 146. North America Fully Automatic Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 147. Latin America Fully Automatic Molecular Diagnostic System Market Size, by Region, 2017-2032 (USD Million)
TABLE 148. Latin America Fully Automatic Molecular Diagnostic System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 149. Latin America Fully Automatic Molecular Diagnostic System Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 150. Latin America Fully Automatic Molecular Diagnostic System Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 151. Latin America Fully Automatic Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 152. Latin America Fully Automatic Molecular Diagnostic System Market Size, by Isothermal Amplification, 2017-2032 (USD Million)
TABLE 153. Latin America Fully Automatic Molecular Diagnostic System Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 154. Latin America Fully Automatic Molecular Diagnostic System Market Size, by Application, 2017-2032 (USD Million)
TABLE 155. Latin America Fully Automatic Molecular Diagnostic System Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 156. Latin America Fully Automatic Molecular Diagnostic System Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 157. Latin America Fully Automatic Molecular Diagnostic System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 158. Latin America Fully Automatic Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
TABLE 159. Latin America Fully Automatic Molecular Diagnostic System Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
TABLE 160. Latin America Fully Automatic Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 161. Europe Fully Automatic Molecular Diagnostic System Market Size, by Region, 2017-2032 (USD Million)
TABLE 162. Europe Fully Automatic Molecular Diagnostic System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 163. Europe Fully Automatic Molecular Diagnostic System Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 164. Europe Fully Automatic Molecular Diagnostic System Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 165. Europe Fully Automatic Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 166. Europe Fully Automatic Molecular Diagnostic System Market Size, by Isothermal Amplification, 2017-2032 (USD Million)
TABLE 167. Europe Fully Automatic Molecular Diagnostic System Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 168. Europe Fully Automatic Molecular Diagnostic System Market Size, by Application, 2017-2032 (USD Million)
TABLE 169. Europe Fully Automatic Molecular Diagnostic System Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 170. Europe Fully Automatic Molecular Diagnostic System Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 171. Europe Fully Automatic Molecular Diagnostic System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 172. Europe Fully Automatic Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
TABLE 173. Europe Fully Automatic Molecular Diagnostic System Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
TABLE 174. Europe Fully Automatic Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 175. Middle East Fully Automatic Molecular Diagnostic System Market Size, by Region, 2017-2032 (USD Million)
TABLE 176. Middle East Fully Automatic Molecular Diagnostic System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 177. Middle East Fully Automatic Molecular Diagnostic System Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 178. Middle East Fully Automatic Molecular Diagnostic System Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 179. Middle East Fully Automatic Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 180. Middle East Fully Automatic Molecular Diagnostic System Market Size, by Isothermal Amplification, 2017-2032 (USD Million)
TABLE 181. Middle East Fully Automatic Molecular Diagnostic System Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 182. Middle East Fully Automatic Molecular Diagnostic System Market Size, by Application, 2017-2032 (USD Million)
TABLE 183. Middle East Fully Automatic Molecular Diagnostic System Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 184. Middle East Fully Automatic Molecular Diagnostic System Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 185. Middle East Fully Automatic Molecular Diagnostic System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 186. Middle East Fully Automatic Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
TABLE 187. Middle East Fully Automatic Molecular Diagnostic System Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
TABLE 188. Middle East Fully Automatic Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 189. Africa Fully Automatic Molecular Diagnostic System Market Size, by Region, 2017-2032 (USD Million)
TABLE 190. Africa Fully Automatic Molecular Diagnostic System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 191. Africa Fully Automatic Molecular Diagnostic System Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 192. Africa Fully Automatic Molecular Diagnostic System Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 193. Africa Fully Automatic Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 194. Africa Fully Automatic Molecular Diagnostic System Market Size, by Isothermal Amplification, 2017-2032 (USD Million)
TABLE 195. Africa Fully Automatic Molecular Diagnostic System Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 196. Africa Fully Automatic Molecular Diagnostic System Market Size, by Application, 2017-2032 (USD Million)
TABLE 197. Africa Fully Automatic Molecular Diagnostic System Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 198. Africa Fully Automatic Molecular Diagnostic System Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 199. Africa Fully Automatic Molecular Diagnostic System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 200. Africa Fully Automatic Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
TABLE 201. Africa Fully Automatic Molecular Diagnostic System Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
TABLE 202. Africa Fully Automatic Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 203. Global Fully Automatic Molecular Diagnostic System Market Size, by Group, 2017-2032 (USD Million)
TABLE 204. ASEAN Fully Automatic Molecular Diagnostic System Market Size, by Group, 2017-2032 (USD Million)
TABLE 205. ASEAN Fully Automatic Molecular Diagnostic System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 206. ASEAN Fully Automatic Molecular Diagnostic System Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 207. ASEAN Fully Automatic Molecular Diagnostic System Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 208. ASEAN Fully Automatic Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 209. ASEAN Fully Automatic Molecular Diagnostic System Market Size, by Isothermal Amplification, 2017-2032 (USD Million)
TABLE 210. ASEAN Fully Automatic Molecular Diagnostic System Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 211. ASEAN Fully Automatic Molecular Diagnostic System Market Size, by Application, 2017-2032 (USD Million)
TABLE 212. ASEAN Fully Automatic Molecular Diagnostic System Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 213. ASEAN Fully Automatic Molecular Diagnostic System Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 214. ASEAN Fully Automatic Molecular Diagnostic System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 215. ASEAN Fully Automatic Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
TABLE 216. ASEAN Fully Automatic Molecular Diagnostic System Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
TABLE 217. ASEAN Fully Automatic Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 218. GCC Fully Automatic Molecular Diagnostic System Market Size, by Group, 2017-2032 (USD Million)
TABLE 219. GCC Fully Automatic Molecular Diagnostic System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 220. GCC Fully Automatic Molecular Diagnostic System Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 221. GCC Fully Automatic Molecular Diagnostic System Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 222. GCC Fully Automatic Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 223. GCC Fully Automatic Molecular Diagnostic System Market Size, by Isothermal Amplification, 2017-2032 (USD Million)
TABLE 224. GCC Fully Automatic Molecular Diagnostic System Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 225. GCC Fully Automatic Molecular Diagnostic System Market Size, by Application, 2017-2032 (USD Million)
TABLE 226. GCC Fully Automatic Molecular Diagnostic System Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 227. GCC Fully Automatic Molecular Diagnostic System Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 228. GCC Fully Automatic Molecular Diagnostic System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 229. GCC Fully Automatic Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
TABLE 230. GCC Fully Automatic Molecular Diagnostic System Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
TABLE 231. GCC Fully Automatic Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 232. European Union Fully Automatic Molecular Diagnostic System Market Size, by Group, 2017-2032 (USD Million)
TABLE 233. European Union Fully Automatic Molecular Diagnostic System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 234. European Union Fully Automatic Molecular Diagnostic System Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 235. European Union Fully Automatic Molecular Diagnostic System Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 236. European Union Fully Automatic Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 237. European Union Fully Automatic Molecular Diagnostic System Market Size, by Isothermal Amplification, 2017-2032 (USD Million)
TABLE 238. European Union Fully Automatic Molecular Diagnostic System Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 239. European Union Fully Automatic Molecular Diagnostic System Market Size, by Application, 2017-2032 (USD Million)
TABLE 240. European Union Fully Automatic Molecular Diagnostic System Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 241. European Union Fully Automatic Molecular Diagnostic System Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 242. European Union Fully Automatic Molecular Diagnostic System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 243. European Union Fully Automatic Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
TABLE 244. European Union Fully Automatic Molecular Diagnostic System Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
TABLE 245. European Union Fully Automatic Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 246. BRICS Fully Automatic Molecular Diagnostic System Market Size, by Group, 2017-2032 (USD Million)
TABLE 247. BRICS Fully Automatic Molecular Diagnostic System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 248. BRICS Fully Automatic Molecular Diagnostic System Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 249. BRICS Fully Automatic Molecular Diagnostic System Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 250. BRICS Fully Automatic Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 251. BRICS Fully Automatic Molecular Diagnostic System Market Size, by Isothermal Amplification, 2017-2032 (USD Million)
TABLE 252. BRICS Fully Automatic Molecular Diagnostic System Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 253. BRICS Fully Automatic Molecular Diagnostic System Market Size, by Application, 2017-2032 (USD Million)
TABLE 254. BRICS Fully Automatic Molecular Diagnostic System Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 255. BRICS Fully Automatic Molecular Diagnostic System Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 256. BRICS Fully Automatic Molecular Diagnostic System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 257. BRICS Fully Automatic Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
TABLE 258. BRICS Fully Automatic Molecular Diagnostic System Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
TABLE 259. BRICS Fully Automatic Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 260. G7 Fully Automatic Molecular Diagnostic System Market Size, by Group, 2017-2032 (USD Million)
TABLE 261. G7 Fully Automatic Molecular Diagnostic System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 262. G7 Fully Automatic Molecular Diagnostic System Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 263. G7 Fully Automatic Molecular Diagnostic System Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 264. G7 Fully Automatic Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 265. G7 Fully Automatic Molecular Diagnostic System Market Size, by Isothermal Amplification, 2017-2032 (USD Million)
TABLE 266. G7 Fully Automatic Molecular Diagnostic System Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 267. G7 Fully Automatic Molecular Diagnostic System Market Size, by Application, 2017-2032 (USD Million)
TABLE 268. G7 Fully Automatic Molecular Diagnostic System Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 269. G7 Fully Automatic Molecular Diagnostic System Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 270. G7 Fully Automatic Molecular Diagnostic System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 271. G7 Fully Automatic Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
TABLE 272. G7 Fully Automatic Molecular Diagnostic System Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
TABLE 273. G7 Fully Automatic Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 274. NATO Fully Automatic Molecular Diagnostic System Market Size, by Group, 2017-2032 (USD Million)
TABLE 275. NATO Fully Automatic Molecular Diagnostic System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 276. NATO Fully Automatic Molecular Diagnostic System Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 277. NATO Fully Automatic Molecular Diagnostic System Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 278. NATO Fully Automatic Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 279. NATO Fully Automatic Molecular Diagnostic System Market Size, by Isothermal Amplification, 2017-2032 (USD Million)
TABLE 280. NATO Fully Automatic Molecular Diagnostic System Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 281. NATO Fully Automatic Molecular Diagnostic System Market Size, by Application, 2017-2032 (USD Million)
TABLE 282. NATO Fully Automatic Molecular Diagnostic System Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 283. NATO Fully Automatic Molecular Diagnostic System Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 284. NATO Fully Automatic Molecular Diagnostic System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 285. NATO Fully Automatic Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
TABLE 286. NATO Fully Automatic Molecular Diagnostic System Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
TABLE 287. NATO Fully Automatic Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 288. Global Fully Automatic Molecular Diagnostic System Market Size, by Country, 2017-2032 (USD Million)
TABLE 289. United States Fully Automatic Molecular Diagnostic System Market Size, 2017-2032 (USD Million)
TABLE 290. United States Fully Automatic Molecular Diagnostic System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 291. United States Fully Automatic Molecular Diagnostic System Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 292. United States Fully Automatic Molecular Diagnostic System Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 293. United States Fully Automatic Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 294. United States Fully Automatic Molecular Diagnostic System Market Size, by Isothermal Amplification, 2017-2032 (USD Million)
TABLE 295. United States Fully Automatic Molecular Diagnostic System Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 296. United States Fully Automatic Molecular Diagnostic System Market Size, by Application, 2017-2032 (USD Million)
TABLE 297. United States Fully Automatic Molecular Diagnostic System Market Size, by Genetic Testing, 2017-2032 (USD Million)
TABLE 298. United States Fully Automatic Molecular Diagnostic System Market Size, by Infectious Disease, 2017-2032 (USD Million)
TABLE 299. United States Fully Automatic Molecular Diagnostic System Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 300. United States Fully Automatic Molecular Diagnostic System Market Size, by End User, 2017-2032 (USD Million)
TABLE 301. United States Fully Automatic Molecular Diagnostic System Market Size, by Academic And Research Institutes, 2017-2032 (USD Million)
TABLE 302. United States Fully Automatic Molecular Diagnostic System Market Size, by Diagnostic Laboratories, 2017-2032 (USD Million)
TABLE 303. Canada Fully Automatic Molecular Diagnostic System Market Size, 2017-2032 (USD Million)
TABLE 304. Canada Fully Automatic Molecular Diagnostic System Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 305. Canada Fully Automatic Molecular Diagnostic System Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 306. Canada Fully Automatic Molecular Diagnostic System Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 307. Canada Fully Automatic Molecular Diagnostic System Market Size, by Technology, 2017-2032 (USD Million)
TABLE 308. Canada Fully Automatic Molecular Diagnostic System Market Size, by Isothermal Amplification, 2017-2032 (USD Million)
TABLE 309. Canada Fully Automatic Molecular Diagnostic System Market Size, by Next Generation Sequ

Companies Mentioned

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biocartis Group NV
  • bioMérieux S.A.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • Hologic, Inc.
  • QIAGEN N.V.
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

Automation in the Molecular Diagnostics Market - Global Forecast 2026-2032 - Product Image

Automation in the Molecular Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
PCR Molecular Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

PCR Molecular Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 115 Pages
  • Global
From
Molecular Methods Market - Global Forecast 2026-2032 - Product Image

Molecular Methods Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Colorectal Cancer Molecular Diagnostics Global Market Opportunities and Strategies to 2034 - Product Image

Colorectal Cancer Molecular Diagnostics Global Market Opportunities and Strategies to 2034

  • Report
  • 359 Pages
  • Global
From
Oncology Molecular Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Oncology Molecular Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 130 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.